Novartis in Barcelona, Spain, is seeking a General Program Safety Lead in Cardio Renal Metabolism to own end-to-end safety strategy for priority programs. Lead safety governance across global teams, drive risk-based decisions, and ensure safety insights shape development and lifecycle decisions.
The role requires 5+ years in drug development, 2+ years in pharmacovigilance, and strong English communication in a matrix, multicultural environment.